Please enable JavaScript.
Coggle requires JavaScript to display documents.
Parkinsons - Coggle Diagram
Parkinsons
Outlook
As the condition progresses, the symptoms of Parkinson's disease can get worse and it can become increasingly difficult to carry out everyday activities without help.
Many people respond well to treatment and only experience mild to moderate disability, whereas the minority may not respond as well and can, in time, become more severely disabled.
Parkinson's disease does not directly cause people to die, but the condition can place great strain on the body, and can make some people more vulnerable to serious and life-threatening infections.
But with advances in treatment, most people with Parkinson's disease now have a normal or near-normal life expectancy.
-
Who's affected
-
Most people with Parkinson's start to develop symptoms when they're over 50, although around 1 in 20 people with the condition first experience symptoms when they're under 40.
-
-
-
About Parkinson’s
Parkinson’s is the fastest growing neurological condition in the world, and currently there is no cure.
Anyone can get Parkinson’s, young or old. In the UK, around 145,000 people are already living with Parkinson’s.
Every hour, two more people are diagnosed. That’s the same as 18,000 people every year. 1 in 37 people alive today will be diagnosed with Parkinson’s in their lifetime.
Prevalence & Incidence
The prevalence of the disease ranges from 41 people per 100,000 in the fourth decade of life to more than 1,900 people per 100,000 among those who are 80 and older.
The prevalence of Parkinson’s in the U.K. is about one in 500 people, with a total of about 127,000 people living with the disease.
The incidence of the disease, or the rate of newly diagnosed cases, generally increases with age, although it can stabilize in people who are older than 80. An estimated 4 percent of people with Parkinson’s are diagnosed before age 50.
-
-
Keeping well
Vaccinations
-
The pneumococcal vaccination is also usually recommended, which is a one-off injection that protects against a serious chest infection called pneumococcal pneumonia.
-
-